iTHRIV Leaders Attend Clinical Translational Science Award Program Meeting
11/29/2022
In early November, members of iTHRIV’s leadership team attended the 2022 Clinical Translational Science Award (CTSA) Program Meeting. UVA’s Karen Johnston MD, MSc and Sandra Burks, RN were joined by…
NIH Policy for Data Management and Sharing Effective January 25, 2023
11/29/2022
NIH has issued a final Policy for Data Management and Sharing (DMS Policy) to promote the management and sharing of scientific data generated from NIH-funded or conducted research. This policy…
iTHRIV Backs Community-Based Research Projects with $80K in Seed Grants
11/29/2022
The integrated Translational Health Research Institute of Virginia, or iTHRIV, a National Institutes of Health-funded Clinical and Translational Science Award hub, has awarded almost $80,000 in seed funding to two community-focused projects focused…
11/29/2022
UVA School of Medicine researchers have developed an important new tool to help scientists sort signal from noise as they probe the genetic causes of cancer and other diseases. In…
11/8/2022
Firas El Chaer, MD, an assistant professor of medicine who specializes in hematology and oncology, will present preliminary clinical data evaluating investigational agent TP-3654 at the 64th American Society of…
Sula Mazimba, MD, MPH and Kenneth Bilchick, MD, MS Reveal Potential New Treatment for Heart Failure
11/8/2022
A recent single-center, retrospective study of hospitalized patients conducted by UVA Health School of Medicine researchers revealed that colchicine, which is commonly used to treat gout in heart failure, significantly…
Jeff Elias, MD, Focused Ultrasound for Essential Tremor Shows Long-Term Relief
11/8/2022
A scalpel-free, high-tech form of brain surgery pioneered at UVA Health offers long-term relief for patients with essential tremor, a common movement disorder a five-year review shows. The study offers…
Golam Mohi, PhD Research Points to New Treatment for Bone Marrow Cancer
11/8/2022
Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer. The new research from UVA…
